This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Corcoran, R. B. Articles by Scott, M. P. Search for Related Content PubMed PubMed Citation Articles by Corcoran, R. B. Articles by Scott, M. P.

Insulin-like Growth Factor 2 Is Required for Progression to Advanced Medulloblastoma in patched1 Heterozygous Mice

Departments of Developmental Biology, Genetics, and Bioengineering, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California

Requests for reprints: Matthew P. Scott, Howard Hughes Medical Institute, Clark Center W252, 318 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305. Phone: 650-725-7680; Fax: 650-725-2952; E-mail: mscott{at}stanford.edu.

Key Words: hedgehog • igf2 • medulloblastoma • patched • math1

Medulloblastoma (MB) can arise in the cerebellum due to genetic activation of the Sonic Hedgehog (Shh) signaling pathway. During normal cerebellum development, Shh spurs the proliferation of granule neuron precursors (GNP), the precursor cells of MB. Mutations in the Shh receptor gene patched1 (ptc1+/–) lead to increased MB incidence in humans and mice. MB tumorigenesis in mice heterozygous for ptc1+/– shows distinct steps of progression. Most ptc1+/– mice form clusters of preneoplastic cells on the surface of the mature cerebellum that actively transcribe Shh target genes. In 15% of mice, these preneoplastic cells will become fast-growing, lethal tumors. It was previously shown that the loss of function of insulin-like growth factor 2 (igf2) suppresses MB formation in ptc1+/– mice. We found that igf2 is not expressed in preneoplastic lesions but is induced as these lesions progress to more advanced MB tumors. Igf2 is not required for formation of preneoplastic lesions but is necessary for progression to advanced tumors. Exogenous Igf2 protein promoted proliferation of MB precursor cells (GNP) and a MB cell line, PZp53^MED. Blocking igf2 signaling inhibited growth of PZp53^MED cells, implicating igf2 as a potential clinical target. [Cancer Res 2008;68(21):8788–95]

This article has been cited by other articles:

				J.-W. Theunissen and F. J. de Sauvage Paracrine Hedgehog Signaling in Cancer Cancer Res., August 1, 2009; 69(15): 6007 - 6010. [Abstract] [Full Text] [PDF]